Measuring the Association of Proliferative Breast Lesions to Carcinoma

被引：0
|
作者：
Ziemba, Yonah [1 ]
Chen, Feifan [1 ]
Gold, Shaul [2 ]
Angert, Mallorie [3 ]
Reddy, Kalpana [4 ]
Edelman, Morris [5 ]
机构：
[1] Northwell Hlth, New Hyde Pk, NY USA
[2] New York Life Insurance Co, Flushing, NY USA
[3] Donald & Barbara Zucker Sch Med Hofstra Northwell, Lake Success, NY USA
[4] Northwell Hlth, Garden City, NY USA
[5] Donald & Barbara Zucker Sch Med Hofstra Northwell, New Hyde Pk, NY USA
来源：
MODERN PATHOLOGY | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
297
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Telomerase activity (TA) is not a marker of malignancy in proliferative breast lesions
    Poremba, C
    Willenbring, H
    Schäfer, KL
    Diallo, R
    Otterbach, F
    Dockhorn-Dworniczak, B
    Böcker, W
    LABORATORY INVESTIGATION, 1998, 78 (01) : 25A - 25A
  • [42] Intranuclear inclusions in epithelial cells of benign proliferative breast lesions
    Harada, Oi
    Hoe, Rebecca
    Lin, Jieyan
    Thike, Aye Aye
    Jara-Lazaro, Ana Richelia
    Petersson, Fredrik
    Tan, Puay Hoon
    JOURNAL OF CLINICAL PATHOLOGY, 2011, 64 (09) : 776 - 780
  • [43] A DILUTIONAL IMMUNOPEROXIDASE STUDY OF PROLIFERATIVE DUCTAL LESIONS AND CARCINOMATA OF THE BREAST
    WELLS, S
    HASLETON, PS
    HISTOPATHOLOGY, 1981, 5 (05) : 517 - 526
  • [44] Quality of life is adversely affected by the diagnosis of proliferative breast lesions
    Albright, Emily
    Sugg, Sonia
    Erdahl, Lillian
    Weigel, Ronald
    Lizarraga, Ingrid
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : 58 - 59
  • [45] Telomerase activity (TA) is not a marker of malignancy in proliferative breast lesions
    Poremba, C
    Willenbring, H
    Schafer, KL
    Diallo, R
    Otterbach, F
    Dockhorn-Dworniczak, B
    Bocker, W
    MODERN PATHOLOGY, 1998, 11 (01) : 25A - 25A
  • [46] LOW DOSE TAMOXIFEN AS TREATMENT OF BENIGN BREAST PROLIFERATIVE LESIONS
    Balalau, Cristian
    Voiculescu, Stefan
    Motofei, Ion
    Scaunasu, Razvan Valentin
    Negrei, Carolina
    FARMACIA, 2015, 63 (03) : 371 - 375
  • [47] Intraductal Proliferative Lesions of the Breast-Terminology and BiologyMatter: Premalignant Lesions or Preinvasive Cancer?
    Costarelli, Leopoldo
    Campagna, Domenico
    Mauri, Maria
    Fortunato, Lucio
    INTERNATIONAL JOURNAL OF SURGICAL ONCOLOGY, 2012, 2012
  • [48] Proliferative and other lesions of the male breast - With notes on 2 cases of proliferative mastitis in stilbcestrol workers
    Scarff, RW
    Smith, CP
    BRITISH JOURNAL OF SURGERY, 1942, 29 (116) : 393 - 396
  • [49] Insulin-like Growth Factor Receptor-1 (IGF-1R) Expression in Normal Breast, Proliferative Breast Lesions, and Breast Carcinoma
    Bhargava, Rohit
    Beriwal, Sushil
    McManus, Kim
    Dabbs, David J.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2011, 19 (03): : 218 - 225
  • [50] The Use of Breast MRI for Surveillance of Patients at High Risk for Breast Cancer Secondary to a Previous Diagnosis of Atypical Proliferative Lesions and/or Lobular Carcinoma In Situ
    Schwartz, Theresa
    Cyr, Amy
    Rastelli, Antonella
    Appleton, Catherine
    Margenthaler, Julie
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : 105 - 105
12345